Skip to main content
Article thumbnail
Location of Repository

Estimating the cost related to surveillance of colorectal cancer in a French population

By Catherine Lejeune, Christine Binquet, Franck Bonnetain, Amel Mahboubi, Michal Abrahamowicz, Thierry Moreau, Maria Raikou, Laurent Bedenne, Catherine Quantin and Claire Bonithon-Kopp


Little is known about costs related to the surveillance of patients that have undergone curative resection of colorectal cancer. The aim of this study was to calculate the observed surveillance costs for 385 patients followed-up over a 3-year period, to estimate surveillance costs if French guidelines are respected, and to identify the determinants related to surveillance costs to derive a global estimation for France, using a linear mixed model. The observed mean surveillance cost was € 713. If French recommendations were strictly applied, the estimated mean cost would vary between € 680 and € 1,069 according to the frequency of abdominal ultrasound. The predicted determinants of cost were: age, recurrence, duration of surveillance since diagnosis, and adjuvant treatments. For France, the surveillance cost represented 4.4% of the cost of colorectal cancer management. The cost of surveillance should now be balanced with its effectiveness and compared with surveillance alternatives

Topics: RA Public aspects of medicine
Publisher: Springer
Year: 2009
DOI identifier: 10.1007/s10198-009-0144-7
OAI identifier:
Provided by: LSE Research Online
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.